Comparative Pharmacology
Head-to-head clinical analysis: ALPHAREDISOL versus RUBRAMIN PC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALPHAREDISOL versus RUBRAMIN PC.
ALPHAREDISOL vs RUBRAMIN PC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cyanocobalamin (vitamin B12) acts as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. Alpharedisol is a cyanocobalamin formulation that corrects vitamin B12 deficiency.
Cyanocobalamin (vitamin B12) is essential for DNA synthesis, myelin formation, and hematopoiesis. It acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase.
Hydroxocobalamin 1 mg intramuscularly once daily for 5-10 days, then 1 mg once monthly for life.
1000 mcg intramuscularly once daily for 5-7 days, then 1000 mcg intramuscularly once weekly for 4 weeks, followed by 1000 mcg intramuscularly once monthly.
None Documented
None Documented
1.5 hours in healthy adults; prolonged to 3-6 hours in renal impairment
Terminal elimination half-life: 6-7 hours in normal renal function; prolonged to 7-10 hours in elderly; significantly extended in renal impairment (up to 80 hours in ESRD), requiring dose adjustment
Renal (90% as unchanged drug); biliary/fecal (10%)
Renal: 50-98% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: <1%
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement